Ischemic tissue parenchymal cells

Ischemic tissue parenchymal cells refer to the functional, organ-specific cells—such as cardiomyocytes in the heart, neurons in the brain, or renal tubular cells in the kidney—that are undergoing a state of ischemia, characterized by a critical reduction in blood flow and oxygen supply [1]. This physiological state leads to a shift from aerobic to anaerobic metabolism, resulting in ATP depletion, intracellular acidosis, and the accumulation of reactive oxygen species, which ultimately trigger cell death pathways like apoptosis and necrosis [2, 3]. While these cells are the primary focus of therapeutic efforts in conditions such as myocardial infarction and stroke, they do not represent a single molecular target; rather, they are a complex cellular environment containing various potential targets like ion channels, metabolic enzymes, and signaling proteins [4]. Therapeutic strategies aimed at these cells generally focus on restoring perfusion or providing cytoprotection to prevent irreversible damage during the ischemic insult and the subsequent reperfusion phase [3, 5]. The preservation of these cells is the gold standard for evaluating the efficacy of reperfusion therapies and neuroprotective or cardioprotective agents [4]. Challenges in targeting these cells include the narrow therapeutic window following the onset of ischemia and the risk of exacerbating damage through reperfusion-induced oxidative stress [3]. Sources: [1] StatPearls, "Physiology, Ischemia", https://www.ncbi.nlm.nih.gov/books/NBK482238/ [2] National Cancer Institute, "Parenchyma", https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parenchyma [3] Kalogeris, T., et al. (2012), "Cell Biology of Ischemia/Reperfusion Injury", https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904795/ [4] Eltzschig, H. K., & Eckle, T. (2011), "Ischemia and reperfusion—from mechanism to translation", https://www.nature.com/articles/nm.2507 [5] NIH, "Ischemic Stroke", https://www.ninds.nih.gov/health-information/disorders/ischemic-stroke

Other names

Ischemic parenchymaHypoxic parenchymal cellsIschemic organ cellsInfarcted tissue cells

Not applicable as a single molecular mechanism; drugs targeting the condition of these cells act via thrombolysis, anti-platelet aggregation, calcium channel blockade, or metabolic modulation to preserve cell viability.